Avant Diagnostics' Newly Appointed President & CEO Philippe Goix Delivered an Address to Shareholders

GAITHERSBURG, Maryland, September 27, 2017 /PRNewswire/ --Avant Diagnostics, Inc. ("Avant" or the "Company") (OTC: AVDX), an oncology-focused healthcare technology company commercializing the proprietary Theralink® phospho-protein biomarker platform across multiple cancers, today...